130 related articles for article (PubMed ID: 6011469)
1. [On the immunizing properties of GOAL-formol vaccine and GNKI dry virus vaccine against foot-and-mouth disease].
Lazarev PS; Amelin IP; Zaslonov MS
Veterinariia; 1966 Sep; 43(9):30-1. PubMed ID: 6011469
[No Abstract] [Full Text] [Related]
2. [Testing the activity of anti-foot-and-mouth disease aluminum hydroxide formol vaccine on guinea pigs].
Kuleshova LA; Kozlovskiĭ GA; Sorvachev EV; Murashkin VI
Veterinariia; 1969 May; 5():25-7. PubMed ID: 5381315
[No Abstract] [Full Text] [Related]
3. The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines.
Hyslop NS; Morrow AW
Res Vet Sci; 1969 Mar; 10(2):109-20. PubMed ID: 5818030
[No Abstract] [Full Text] [Related]
4. [On the production of monovalent foot-and-mouth disease vaccine concentrate from tissue culture virus type O].
Mitev G; Wassilewa L; Tekerlekov P
Arch Exp Veterinarmed; 1966 Mar; 20(1):85-90. PubMed ID: 4293436
[No Abstract] [Full Text] [Related]
5. [Immunogenic properties of inactivated cultured foot-and-mouth disease vaccine].
Siusiukin AA; Kravets IK; Siusiukina MS; Efimov NI; Sergeev VA; Mel'nik RI
Veterinariia; 1967 Apr; 44(4):17-8. PubMed ID: 5615318
[No Abstract] [Full Text] [Related]
6. [Determination of formol in foot-and-mouth disease vaccines by the iodometric method].
Strobbe R
Bull Off Int Epizoot; 1965; 63(5):883-90. PubMed ID: 5892237
[No Abstract] [Full Text] [Related]
7. [Control of the activity of anti-foot-and-mouth disease GOA-formol vaccine on mice].
Kuleshova LA; Kozlovskiĭ GA; Sorvachev EV; Gorokhova MP; Murashkin VI; Andriunin IuI
Veterinariia; 1969 Sep; 9():26-8. PubMed ID: 5369066
[No Abstract] [Full Text] [Related]
8. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test.
Goris N; Maradei E; D'Aloia R; Fondevila N; Mattion N; Perez A; Smitsaart E; Nauwynck HJ; La Torre J; Palma E; De Clercq K
Vaccine; 2008 Jun; 26(27-28):3432-7. PubMed ID: 18499310
[TBL] [Abstract][Full Text] [Related]
9. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
10. [The control of a foot-and mouth disease outbreak with a homologous aluminium-adsorbed vaccine prepared from the organs of a newborn unfed calf].
Seifert HS
Zentralbl Veterinarmed B; 1966 Jun; 13(3):306-16. PubMed ID: 6007875
[No Abstract] [Full Text] [Related]
11. [Immunogenic properties of an experimental vaccine against foot-and-mouth disease].
Siusiukin AA; Kravets IK; Tsvetkova NE; Pavlov VG
Veterinariia; 1971 May; 5():40-2. PubMed ID: 5158658
[No Abstract] [Full Text] [Related]
12. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
Barteling SJ; Cassim NI
Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
[TBL] [Abstract][Full Text] [Related]
13. [Comparative immunologic study on cattle of 2 strains of foot-and-mouth disease type O virus: O Flanders and O Spain 64].
Fontaine J; Gayot G; Dubouclard C; Dhennin L; Roumiantzeff M; Terre J; Dhennin L
Bull Off Int Epizoot; 1966; 65(11):2051-62. PubMed ID: 5994044
[No Abstract] [Full Text] [Related]
14. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
Brehm KE; Kumar N; Thulke HH; Haas B
Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
[TBL] [Abstract][Full Text] [Related]
15. Standards for modified strain vaccines in foot-and-mouth disease.
Brooksby JB
Bull Off Int Epizoot; 1966; 65(11):1941-7. PubMed ID: 5994041
[No Abstract] [Full Text] [Related]
16. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
Sen AK; Saha SN
Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
[TBL] [Abstract][Full Text] [Related]
17. Selection of foot and mouth disease vaccine strains--a review.
Paton DJ; Valarcher JF; Bergmann I; Matlho OG; Zakharov VM; Palma EL; Thomson GR
Rev Sci Tech; 2005 Dec; 24(3):981-93. PubMed ID: 16642769
[TBL] [Abstract][Full Text] [Related]
18. Past and present vaccine development strategies for the control of foot-and-mouth disease.
Balamurugan V; Kumar RM; Suryanarayana VV
Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
[TBL] [Abstract][Full Text] [Related]
19. Proceedings: Quantitative assay of the immunizing dose of monovalent vaccines against foot-and-mouth disease prepared from the virus propagated on cattle tongue mucosa and in culture after Frenkel.
Wiśniewski J; Kobusiewicz T; Szkilnik S; Baranowski C; Jankowska J; Labecka W
Acta Microbiol Pol A; 1974; 6(1):131. PubMed ID: 4364054
[No Abstract] [Full Text] [Related]
20. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
